Schulte Tobias L, Keiler Alexander, Riechelmann Felix, Lange Tobias, Schmoelz Werner
Department of Orthopedics and Tumor Orthopedics, Münster University Hospital, Münster, Germany.
Eur Spine J. 2013 Dec;22(12):2695-701. doi: 10.1007/s00586-013-2908-0. Epub 2013 Jul 24.
Vertebral augmentation with PMMA is a widely applied treatment of vertebral osteoporotic compression fractures. Subsequent fractures are a common complication, possibly due to the relatively high stiffness of PMMA in comparison with bone. Silicone as an augmentation material has biomechanical properties closer to those of bone and might, therefore, be an alternative. The study aimed to investigate the biomechanical differences, especially stiffness, of vertebral bodies with two augmentation materials and two filling grades.
Forty intact human osteoporotic vertebrae (T10-L5) were studied. Wedge fractures were produced in a standardized manner. For treatment, PMMA and silicone at two filling grades (16 and 35 % vertebral body fill) were assigned to four groups. Each specimen received 5,000 load cycles with a high load range of 20-65 % of fracture force, and stiffness was measured. Additional low-load stiffness measurements (100-500 N) were performed for intact and augmented vertebrae and after cyclic loading.
Low-load stiffness testing after cyclic loading normalized to intact vertebrae showed increased stiffness with 35 and 16 % PMMA (115 and 110 %) and reduced stiffness with 35 and 16 % silicone (87 and 82 %). After cyclic loading (high load range), the stiffness normalized to the untreated vertebrae was 361 and 304 % with 35 and 16 % PMMA, and 243 and 222 % with 35 and 16 % silicone augmentation. For both high and low load ranges, the augmentation material had a significant effect on the stiffness of the augmented vertebra, while the filling grade did not significantly affect stiffness.
This study for the first time directly compared the stiffness of silicone-augmented and PMMA-augmented vertebral bodies. Silicone may be a viable option in the treatment of osteoporotic fractures and it has the biomechanical potential to reduce the risk of secondary fractures.
聚甲基丙烯酸甲酯(PMMA)椎体强化术是治疗骨质疏松性椎体压缩骨折的一种广泛应用的方法。后续骨折是一种常见并发症,可能是由于PMMA相对于骨骼的刚度较高。硅酮作为一种强化材料,其生物力学特性更接近骨骼,因此可能是一种替代选择。本研究旨在调查两种强化材料和两种填充等级的椎体的生物力学差异,尤其是刚度。
研究了40个完整的人骨质疏松椎体(T10-L5)。以标准化方式制造楔形骨折。为了进行治疗,将两种填充等级(16%和35%椎体填充)的PMMA和硅酮分为四组。每个标本承受5000次加载循环,高负荷范围为骨折力的20%-65%,并测量刚度。对完整和强化的椎体以及循环加载后进行额外的低负荷刚度测量(100-500 N)。
循环加载后相对于完整椎体的低负荷刚度测试显示,35%和16%的PMMA使刚度增加(分别为115%和110%),35%和16%的硅酮使刚度降低(分别为87%和82%)。循环加载(高负荷范围)后,相对于未治疗椎体的刚度,35%和16%的PMMA分别为361%和304%,35%和16%的硅酮强化分别为243%和222%。对于高负荷和低负荷范围,强化材料对强化椎体的刚度有显著影响,而填充等级对刚度没有显著影响。
本研究首次直接比较了硅酮强化和PMMA强化椎体的刚度。硅酮可能是治疗骨质疏松性骨折的一种可行选择,并且具有降低二次骨折风险的生物力学潜力。